An investigation on behalf of investors of Akorn, Inc. (NASDAQ:AKRX) in connection with the proposed takeover was announced and NASDAQ:AKRX stockholders should contact the Shareholders Foundation.
San Diego, CA -- (SBWIRE) -- 05/02/2017 -- The takeover of Akron, Inc is under investigation over potential wrongdoing. The investigation was announced on behalf of investors, who currently hold NASDAQ:AKRX shares concerning whether the takeover of Akorn, Inc. by Fresenius Kabi is unfair.
Investors who purchased shares of Akorn, Inc. (NASDAQ:AKRX) and currently hold any of those NASDAQ:AKRX shares have certain options and should contact the Shareholders Foundation at email@example.com or call 858-779-1554.
On April 24, 2017, Fresenius Kabi has agreed to acquire Akorn (NASDAQ: AKRX) for approximately $4.3 billion, or $34.00 a share, plus the assumption of approximately $450 million of debt1. The transaction is expected to close by early 2018 and to be accretive in 2018 to Fresenius Group net income and EPS, excluding integration costs.
The investigation by a law firm concerns whether certain officers and directors of Akorn, Inc. breached their fiduciary duties owed to NASDAQ:AKRX investors in connection with the proposed acquisition. More specifically, the investigation concerns whether the Akorn Board of Directors undertook an adequate sales process, adequately shopped the company before entering into the transaction, maximized shareholder value by negotiating the best price, and acted in the shareholders' best interests in connection with the proposed sale.
On May 1, 2017, NASDAQ:AKRX shares closed at $33.32 per share.
Those who are current investors in Akorn, Inc. shares have certain options and should contact the Shareholders Foundation.
Shareholders Foundation, Inc.
3111 Camino Del Rio North - Suite 423
92108 San Diego